Cartalax
aka Ala-Glu-Asp
Mechanism
Cartalax is a synthetic tripeptide (Ala-Glu-Asp / AED) from the Khavinson bioregulator series, studied in Russian preclinical models on fibroblast and chondrocyte cultures. Not FDA-approved; no Western clinical trials exist, and all published evidence originates from a single research group.
Identification
| Molecular formula | C12H19N3O8 |
|---|---|
| Sequence | AED |
| Typical dose | 10–100 mcg/day subcutaneous, 10–20 day cycles |
| Half-life | ~30 minutes |
Vendors selling Cartalax
| Vendor | Size | Price | Listed purity | Trust |
|---|---|---|---|---|
| Glacier Aminos | 20 mg | $67.99 | — | 99 |
| BioLongevity Labs | 20 mg | $69.97 | — | 96 |
| Orbitrex Peptides | 20 mg | $149.99 | — | 95 |
| Ion Peptide | 40 mg | $129.00 | — | 95 |
| Ion Peptide | 20 mg | $79.00 | — | 95 |
| Peptide Tech | 20 mg | $38.99 | — | 94 |
| Mile High Compounds | — | $69.99 | — | 94 |
| Skye Peptides | 25 mg | $59.00 | — | 90 |
| Peptidology | 20 mg | $65.00 | — | 89 |
| Verified Peptides | 20 mg | $55.00 | — | 86 |
| EZ Peptides | 10 mg | $58.00 | — | 85 |
| Peptidegurus | 20 mg | — | — | 84 |
| Cocer Peptides | 20 mg | $160.00 | — | 82 |
| OROS Research | 20 mg | — | — | 79 |
| Certified Peptides | 20 mg | $105.00 | — | 62 |
| NG Peptide | 25 mg | $70.00 | — | — |
| Ruo Bio | 20 mg | $48.00 | — | — |
| Atomik Labz | 10 mg | $159.00 | — | — |
| Atomik Labz | 20 mg | $65.00 | — | — |
| Core Peptides | 20 mg | $63.00 | — | — |
| Flawless Compounds | — | — | — | — |
| Modern Research Peptides | 20 mg | $54.99 | — | — |
| Paramount Peptides | 25 mg | $60.00 | — | — |
| Peptide Crafters | 30 mg | $55.00 | — | — |
| Solution Peptides | 10 mg | $159.00 | — | — |
| Solution Peptides | 20 mg | $65.00 | — | — |
| Wellness Peptides | — | $55.00 | — | — |
Research
Malnutrition is a common challenge in patients with pancreatic cancer undergoing cephalic pancreaticoduodenectomy (CPD), impacting postoperative recovery and overall prognosis. Nutritional support plays a crucial role in optimising metabolic, inflammatory, and digestive outcomes.
source →Ultrashort peptides (USPs), consisting of 2-7 amino-acid residues, are a group of signaling molecules that regulate gene expression and protein synthesis under normal conditions in various diseases and ageing. USPs serve as a basis for the development of drugs with a targeted mechanism of action.
source →Peptides are characterized by their wide range of biological activity: they regulate functions of the endocrine, nervous, and immune systems.
source →